Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...

Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.

The World Health Organization (WHO) wants the labels that warn of tumor risk on the bottles and alcohol cans. Thus ...

Just five months after giving birth to our third (and final) child in 2015, my wife experienced something odd: Her smile ...

Head and neck cancer is diagnosed in at least 700,000 patients each year. A team of 27 doctors has found a comforting means ...

Mouth and throat cancers are highly treatable if caught early, but they are often diagnosed at later stages because people ...